These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7845946

  • 1. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Sato S, Wyman M.
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [Abstract] [Full Text] [Related]

  • 2. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Neuenschwander H, Takahashi Y, Kador PF.
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155
    [Abstract] [Full Text] [Related]

  • 4. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 5. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S, Mori K, Wyman M, Kador PF.
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [Abstract] [Full Text] [Related]

  • 6. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]

  • 7. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Akagi Y, Neuenschwander H, Greentree W, Lackner P, Blessing K, Wyman M.
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [Abstract] [Full Text] [Related]

  • 8. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Terubayashi H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
    [Abstract] [Full Text] [Related]

  • 9. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG, Nagata M, Laver N, Hohman TC, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [Abstract] [Full Text] [Related]

  • 10. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
    Akagi Y, Kador PF.
    Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
    [Abstract] [Full Text] [Related]

  • 11. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y, Terubayashi H, Ikebe H, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract] [Full Text] [Related]

  • 12. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M, Chew EY, Ferris F, Cox TA, Chan CC, Kador PF.
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of retinal vessel changes in galactose-fed dogs.
    Takahashi Y, Augustin W, Wyman M, Kador PF.
    J Ocul Pharmacol; 1993 Dec; 9(3):257-69. PubMed ID: 8228533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progression of sugar cataract in the dog.
    Sato S, Takahashi Y, Wyman M, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [Abstract] [Full Text] [Related]

  • 18. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN, Amin R, Kennedy A, Hohman TC.
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [Abstract] [Full Text] [Related]

  • 19. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973
    [Abstract] [Full Text] [Related]

  • 20. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG, Nagata M, Tillis TN, Laver N, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.